Publications by authors named "Mona Kimmig"
EBioMedicine
October 2023
Article Synopsis
- PD-1-based immune checkpoint inhibitors are key treatments for melanoma, and tumor PD-L1 expression is a crucial biomarker for predicting therapy success.
- This study analyzed PD-L1 levels from various tumor tissues, including primary tumors and metastases, from 448 patients who received treatment between 2014 and 2020, comparing their correlation with treatment outcomes like best overall response and survival rates.
- Results showed that PD-L1 positivity in lymph node metastases was significantly associated with better treatment responses and overall survival, while primary tumors and skin/subcutaneous metastases showed weaker correlations.
